Inhibition of intracellular growth of Mycobacterium avium by one pulsed exposure of infected macrophages to clarithromycin
Open Access
- 1 June 1993
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 37 (6) , 1380-1382
- https://doi.org/10.1128/aac.37.6.1380
Abstract
A single 2-h pulsed exposure of either human monocyte-derived macrophages or J774 cells infected with Mycobacterium avium to clarithromycin at 3.0 micrograms/ml completely inhibited the intracellular bacterial growth during the first four days of observation, and then only a slight increase in the number of CFU per milliliter took place between the fourth and seventh days. These data suggest that in vivo the intracellular bacteria can be effectively inhibited after a short period when the concentration of the drug in blood reaches its maximum. On the basis of these data, the assumptions that the elimination of bacteremia observed in clarithromycin clinical trials is a result of the activity of the drug not only against bacteria in blood but in macrophages as well and that the peak concentration attainable in blood is essential for these effects can be made.Keywords
This publication has 11 references indexed in Scilit:
- MICs and MBCs of clarithromycin against Mycobacterium avium within human macrophagesAntimicrobial Agents and Chemotherapy, 1993
- Comparison of the intracellular activities of clarithromycin and erythromycin against Mycobacterium avium complex strains in J774 cells and in alveolar macrophages from human immunodeficiency virus type 1-infected individualsAntimicrobial Agents and Chemotherapy, 1992
- Clarithromycin Minimal Inhibitory and Bactericidal Concentrations againstMycobacterium aviumAmerican Review of Respiratory Disease, 1992
- Activity of Clarithromycin againstMycobacterium aviumInfection in Patients with the Acquired Immune Deficiency Syndrome: A Controlled Clinical TrialAmerican Review of Respiratory Disease, 1991
- Activities of sparfloxacin, azithromycin, temafloxacin, and rifapentine compared with that of clarithromycin against multiplication of Mycobacterium avium complex within human macrophagesAntimicrobial Agents and Chemotherapy, 1991
- Extracellular and intracellular activities of clarithromycin used alone and in association with ethambutol and rifampin against Mycobacterium avium complexAntimicrobial Agents and Chemotherapy, 1991
- Activities of clarithromycin, sulfisoxazole, and rifabutin against Mycobacterium avium complex multiplication within human macrophagesAntimicrobial Agents and Chemotherapy, 1990
- In vitro and in vivo activities of clarithromycin against Mycobacterium aviumAntimicrobial Agents and Chemotherapy, 1989
- New directions for macrolide antibiotics: pharmacokinetics and clinical efficacyAntimicrobial Agents and Chemotherapy, 1989
- Effectiveness of Ofloxacin againstMycobacterium tuberculosisandMycobacterium avium, and Rifampin againstM. tuberculosisin Cultured Human MacrophagesAmerican Review of Respiratory Disease, 1988